Abstract
Antiphospholipid syndrome (APS) is one of the main acquired causes of thrombosis and pregnancy loss. To date, lifelong anticoagulation remains the only recommended treatment for thrombotic complications in APS. Despite anticoagulation, recurrence rates are high, and prevention of arterial and microvascular disease, which leads to organ damage, is insufficient. On the other hand, treatment…